Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation in Patients With Pulmonary Arterial Hypertension

NCT06802380 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT06802380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06802380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation in Patients With Pulmonary Arterial Hypertension
Lead sponsor
University of Oklahoma
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
December 31, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension